This relates to the understanding of the key role that VEGF/VEGFR plays as part of the resistance mechanism to ICIs, and that VEGF/VEGFR molecular signalling can act as an immunological modulator; when activated in lung cancer, it can render the tumor microenvironment (TME) immunosuppressive [25,26]. The gene discussed is KDR; the disease is neoplasm.